CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 147,533 enrolled
Drug / intervention
HCV Screeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04003454
NCT04003454N/ACompleted

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial

Denver Health and Hospital Authority·interventional·Posted Jul 1, 2019·Updated Feb 6, 2025

In Brief

A clinical study evaluating HCV Screening for Hepatitis C. Completed, enrolled 147,533 participants across 3 sites.

Detailed Summary

The investigators propose to compare the effectiveness of nontargeted rapid opt-out hepatitis C (HCV) screening versus targeted rapid opt-out HCV screening using recommended risk characteristics in multiple urban emergency departments (EDs) across the United States (Aim 1 - "Screening Trial").

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 1, 2019
Enrollment StartNov 20, 2019
Primary CompletionJul 31, 2023
Study CompletionJan 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 7.0 years ago

Interventions

HCV Screeningother

The investigators will perform a prospective pragmatic randomized effectiveness trial that will allow the investigators to directly compare 2 HCV screening methods while minimizing threats to internal validity. Patients will be screened for HCV infection using 1 of 2 interventions using a balanced patient-level random allocation scheme built into existing EHRs for each ED.